Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: KLH who wrote (2455)	1/14/1999 7:37:00 PM
From: BWAC	Read Replies (2) \| Respond to of 2553

KLH I don't know about that. But I did listen in on the conference call. It lasted about 25 minutes if you have the time. Only 3 analyst questions. Anyway there were what I considered 3 key points: 1.)The SG Cowen analyst was very concerned about when GENZL would show a profit. Asked specifically if it would be in the 4th Quarter of 1999. Answer was NO. But it was implied by GENZL that reasonably profits would come 2 Quarters after that, given the current rate of Carticel sales growth and something done with the Diacrin agreement. It would be interesting to see the analysts new report. Anybody? 2.)Something will be done to relieve GENZL of some or all of the Diacrin agreement, but no specifics were given. It seemed that this was the news the analysts wanted to hear. 3.)GENZL is working on a treatment protocol with Blue Cross Blue Shield.